Carsten Niemann

Carsten Niemann

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
1 - 10 out of 18Page size: 10
  1. 2023
  2. Published

    CD3xCD20 Bispecific Antibodies Yields Long-Term Survival in Relapsed/Refractory B Cell Lymphoma: A Follow-up Study of Patients Treated in Pivotal Phase 1/2 Trials

    Kyvsgaard, Emil Ramsø, Clausen, M. R., Hasselbalch Riley, A. C., Niemann, Carsten, Grønbæk, Kirsten, Hutchings, M. & Husby, Simon, 28 Nov 2023, In: Blood. 142, Supplement 1, p. 618-618

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Immunohistochemical Tumor Expression Predicts Response to CD3xCD20 Bispecific Antibodies in Patients with Relapsed/Refractory B Cell Lymphoma

    Kyvsgaard, Emil Ramsø, Clausen, M. R., Hasselbalch Riley, A. C., Niemann, Carsten, Sjö, Lene Dissing, Grønbæk, Kirsten, Hutchings, M. & Husby, Simon, 28 Nov 2023, In: Blood. 142, Supplement 1, p. 6113-6113

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Readmissions, Postdischarge Mortality, and Sustained Recovery Among Patients Admitted to Hospital With Coronavirus Disease 2019 (COVID-19)

    Moestrup, K. S., Reekie, J., Zucco, Adrian G., Jensen, T. Ø., Jensen , Jens-Ulrik Stæhr , Wiese, L., Ostrowski, Sisse Rye, Niemann, Carsten, MacPherson, C. R., Lundgren, Jens & Helleberg, Marie, 8 Feb 2023, In: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 76, 3, p. e82-e89 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    BTK inhibitors: safety + efficacy = outcome

    Niemann, Carsten, 2023, In: Blood. 142, 8, p. 679-680 2 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  6. Published

    Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Mansouri, L., Thorvaldsdottir, B., Sutton, L. A., Karakatsoulis, G., Meggendorfer, M., Parker, H., Nadeu, F., Brieghel, C., Laidou, S., Moia, R., Rossi, D., Catherwood, M., Kotaskova, J., Delgado, J., Rodríguez-Vicente, A. E., Benito, R., Rigolin, G. M., Bonfiglio, S., Scarfo, L., Mattsson, M. & 41 others, Davis, Z., Gogia, A., Rani, L., Baliakas, P., Foroughi-Asl, H., Jylhä, C., Skaftason, A., Rapado, I., Miras, F., Martinez-Lopez, J., de la Serna, J., Rivas, J. M. H., Thornton, P., Larráyoz, M. J., Calasanz, M. J., Fésüs, V., Mátrai, Z., Bödör, C., Smedby, K. E., Espinet, B., Puiggros, A., Gupta, R., Bullinger, L., Bosch, F., Tazón-Vega, B., Baran-Marszak, F., Oscier, D., Nguyen-Khac, F., Zenz, T., Terol, M. J., Cuneo, A., Hernández-Sánchez, M., Pospisilova, S., Mills, K., Gaidano, G., Niemann, Carsten, Campo, E., Strefford, J. C., Ghia, P., Stamatopoulos, K. & Rosenquist, R., 2023, In: Leukemia. 37, 2, p. 339-347 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Final analysis of the CLL2-GIVe trial: obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut

    Huber, H., Tausch, E., Schneider, C., Edenhofer, S., von Tresckow, J., Robrecht, S., Giza, A., Zhang, C., Fürstenau, M., Dreger, P., Ritgen, M., Illmer, T., Illert, A. L., Dürig, J., Böttcher, S., Niemann, C. U., Kneba, M., Al-Sawaf, O., Kreuzer, K. A., Fink, A. M. & 5 others, Fischer, K., Döhner, H., Hallek, M., Eichhorst, B. & Stilgenbauer, S., 2023, In: Blood. 142, 11, p. 961-972 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

    Eichhorst, B., Niemann, C. U., Kater, A. P., Fürstenau, M., von Tresckow, J., Zhang, C., Robrecht, S., Gregor, M., Juliusson, G., Thornton, P., Staber, P. B., Tadmor, T., Lindström, V., Da Cunha-Bang, C., Schneider, C., Poulsen, C. B., Illmer, T., Schöttker, B., Nösslinger, T., Janssens, A. & 30 others, Christiansen, I., Baumann, M., Frederiksen, H., Van Der Klift, M., Jäger, U., Leys, M. B. L., Hoogendoorn, M., Lotfi, K., Hebart, H., Gaska, T., Koene, H., Enggaard, L., Goede, J., Regelink, J. C., Widmer, A., Simon, F., De Silva, N., Fink, A., Bahlo, J., Fischer, K., Wendtner, C., Kreuzer, K. A., Ritgen, M., Brüggemann, M., Tausch, E., Levin, M., van Oers, M., Geisler, C., Stilgenbauer, S. & Hallek, M., 2023, In: New England Journal of Medicine. 388, 19, p. 1739-1754 16 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations

    Fürstenau, M., Thus, Y. J., Robrecht, S., Mellink, C. H. M., van der Kevie-Kersemaekers, A. M., Dubois, J., von Tresckow, J., Patz, M., Gregor, M., Thornton, P., Staber, P. B., Tadmor, T., Levin, M. D., da Cunha-Bang, C., Schneider, C., Poulsen, C. B., Illmer, T., Schöttker, B., Janssens, A., Christiansen, I. & 27 others, Nösslinger, T., Baumann, M., Hebart, H., Gaska, T., Regelink, J. C., Dompeling, E. C., Lindström, V., Juliusson, G., Widmer, A., Goede, J., Goldschmidt, N., Simon, F., De Silva, N., Fink, A. M., Fischer, K., Wendtner, C. M., Ritgen, M., Brüggemann, M., Tausch, E., Spaargaren, M., Eldering, E., Stilgenbauer, S., Niemann, Carsten, Hallek, M., Eichhorst, B., Kreuzer, K. A. & Kater, A. P., 2023, In: Blood. 142, 5, p. 446–459

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Ibrutinib sensitizes CLL cells to venetoclax by interrupting TLR9-induced CD40 upregulation and protein translation

    Kielbassa, K., Haselager, M. V., Bax, D. J. C., van Driel, B. F., Dubois, J., Levin, M. D., Kersting, S., Svanberg, R., Niemann, Carsten, Kater, A. P. & Eldering, E., 2023, In: Leukemia. 37, 6, p. 1268-1276 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Immediate COVID-19 treatment in CLL

    Niemann, Carsten, 2023, In: Blood. 141, 18, p. 2167-2168 2 p.

    Research output: Contribution to journal › Editorial › Research › peer-review

Previous 1 2 Next

ID: 185059285